Naslovna strana za rukopis Variations and Implications of Irisin, FGF-23, and N-MID Osteocalcin in Diabetic Osteoporosis Patients Undergoing Acarbose Plus Sitagliptin Therapy: A Prospective Cohort Analysis

Povratak na detalje o rukopisu Variations and Implications of Irisin, FGF-23, and N-MID Osteocalcin in Diabetic Osteoporosis Patients Undergoing Acarbose Plus Sitagliptin Therapy: A Prospective Cohort Analysis Preuzmi Preuzmi PDF